Do elderly systolic heart failure patients benefit from beta blockers to the same extent as the non-elderly?: Meta-analysis of >12,000 patients in large-scale clinical trials

被引：67
作者：
Dulin, BR
Haas, SJ
Abraham, WT
Krum, H
机构：
[1] Monash Univ, Alfred Hosp, NHMRC Ctr Clin Res Excellence Therapeut, Dept Epidemiol, Melbourne, Vic 3004, Australia
[2] Monash Univ, Alfred Hosp, NHMRC Ctr Clin Res Excellence Therapeut, Dept Prevent Med & Med, Melbourne, Vic 3004, Australia
[3] Davis Heart & Lung Res Inst, Columbus, OH USA
[4] Ohio State Univ, Div Cardiovasc Med, Columbus, OH 43210 USA
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2005年 / 95卷 / 07期
关键词：
D O I：
10.1016/j.amjcard.2004.11.052
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A meta-analysis of all-cause mortality data involving elderly and non-elderly chronic heart failure patients from 5 completed beta-blocker trials revealed that elderly and non-elderly chronic heart failure patients derived considerable prognostic benefit from beta-blacker therapy without a statistically significant difference in mortality reduction between the 2 groups. (c) 2005 by Excerpta Medica Inc.
引用
收藏
页码：896 / 898
页数：3
相关论文
共 12 条
[1]  
ALLADA CS, 2002, J AM COLL CARDIOL S, V39, P1113
[2]   A COMPARISON OF STATISTICAL-METHODS FOR COMBINING EVENT RATES FROM CLINICAL-TRIALS [J].
BERLIN, JA ;
LAIRD, NM ;
SACKS, HS ;
CHALMERS, TC .
STATISTICS IN MEDICINE, 1989, 8 (02) :141-151
[3]  
Deeks J.J., 2008, Systematic Reviews in Health Care: Meta-Analysis in Context, Second Edition, P285
[4]  
Eichhorn E, 2001, NEW ENGL J MED, V344, P1659
[5]   Results from post-hoc analyses of the CIBIS II trial: effect of bisoprolol in high-risk patient groups with chronic heart failure [J].
Erdmann, E ;
Lechat, P ;
Verkenne, P ;
Wiemann, H .
EUROPEAN JOURNAL OF HEART FAILURE, 2001, 3 (04) :469-479
[6]   FASTTRACK Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS) [J].
Flather, MD ;
Shibata, MC ;
Coats, AJS ;
Van Veldhuisen, DJ ;
Parkhomenko, A ;
Borbola, J ;
Cohen-Solal, A ;
Dumitrascu, D ;
Ferrari, R ;
Lechat, P ;
Soler-Soler, J ;
Tavazzi, L ;
Spinarova, L ;
Toman, J ;
Böhm, M ;
Anker, SD ;
Thompson, SG ;
Poole-Wilson, PA .
EUROPEAN HEART JOURNAL, 2005, 26 (03) :215-225
[7]   Strengths and limitations of meta-analysis: Larger studies may be more reliable [J].
Flather, MD ;
Farkouh, ME ;
Pogue, JM ;
Yusuf, S .
CONTROLLED CLINICAL TRIALS, 1997, 18 (06) :568-579
[8]  
Hjalmarson Å, 1999, LANCET, V353, P2001
[9]  
Lechat P, 1999, LANCET, V353, P9
[10]   Effect of carvedilol on survival in severe chronic heart failure. [J].
Packer, M ;
Coats, AJS ;
Fowler, MB ;
Katus, HA ;
Krum, H ;
Mohacsi, P ;
Rouleau, JL ;
Tendera, M ;
Castaigne, A ;
Roecker, EB ;
Schultz, MK ;
DeMets, DL .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (22) :1651-1658
12